“…The strength of the association between anticholinergic load and delayed-episodic memory was reduced (OR = 1.43, 95% CI 0.82-2.50, p = 0.21) whereas those of other associations were unchanged (stage of recovery: OR = 1.77, 95% CI 1.04-2.98, p = 0.03; mental well-being: OR = 1.49, 95% CI 0.96-2.30, p = 0.07; medication adherence: OR = 2.27, 95% CI 1.33-3.89, p = 0.003; multiple errands test completion time: OR = 0.59, 95% CI 0.37-0.96, p = 0.03). Second, we restricted the analyses to persons not exposed to clozapine use (n = 908) for comparable reasons (highanticholinergic activity and proxy of illness severity) (Verdoux et al, 2019). The strengths of the associations were unchanged (stage of recovery: OR = 1.78, 95% CI 1.04-3.01, p = 0.03; mental well-being: OR = 1.56, 95% CI 1.0-2.43, p = 0.05; medication adherence: OR = 2.23, 95% CI 1.31-3.79, p = 0.003; delayed-episodic memory: OR = 1.74, 95% CI 0.99-3.07, p = 0.05); multiple errands test completion time: OR = 0.60, 95% CI 0.38-0.95, p = 0.03).…”